Another toxic shock syndrome: Streptococcal infection is even more dangerous than the staphylococcal form

Postgraduate Medicine

Volumn 104, Issue 6, 1998, Pages 31-44

  Hauser, Alan R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE;

ARTICLE; CELLULITIS; CLINICAL FEATURE; DEBRIDEMENT; DISEASE ASSOCIATION; DISEASE COURSE; EARLY DIAGNOSIS; LABORATORY DIAGNOSIS; PATHOGENESIS; PROGNOSIS; PUBLIC HEALTH SERVICE; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; TAMPON; TOXIC SHOCK SYNDROME; WOUND INFECTION;

EID: 0032410760     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.12.392     Document Type: Article

References (18)

1. Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 1993; 269(3):390-1
2. Davies HD, McGeer A, Schwartz B, et al, for the Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med 1996;335(8):547-54
3. Katz AR, Morens DM. Severe streptococcal infections in historical perspective. Clin Infect Dis 1992;14(1):298-307
4. Cone LA, Woodard DR, Schlievert PM, et al. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 1987;317(3):146-9
5. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989;321(1):1-7
6. Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome: a retrospective population-based study. JAMA 1993;269 (3):384-9 [Erratum, JAMA 1993;269(13): 1638]
7. Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med 1997;103(1):18-24
8. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995;1(3):69-78
9. Auerbach SB, Schwartz B, Williams D, et al. Outbreak of invasive group A streptococcal infections in a nursing home: lessons on prevention and control. Arch Intern Med 1992;152(5):1017-22
10. Gamba MA, Martinelli M, Schaad HJ, et al. Familial transmission of a serious disease-producing group A streptococcus clone: case reports and review. Clin Infect Dis 1997;24(6):1118-21
11. Demers B, Simor AE, Vellend H, et al. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993;16(6):792-800; discussion 801-2
12. Brogan TV, Nizet V, Waldhausen JH, et al. Group A streptococcal necrotizing fasciitis complicating primary varicella: a series of fourteen patients. Pediatr Infect Dis J 1995;14(7):588-94
13. Eagle H. Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 1952;13(Oct):389-99
14. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988;158(1):23-8
15. Stevens DL, Yan S, Bryant AE. Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993;167(6):1401-5
16. Perez CM, Kubak BM, Cryer HG, et al. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review. Am J Med 1997;102(1):111-3
17. Smith RJ, Berk SL. Necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. South Med J 1991;84(6):785-7
18. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21(4):977-80